| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/27/2013 | CN101475513B Raf and HDAC small molecular double inhibitor, and preparation and use thereof |
| 02/27/2013 | CN101461814B Medicament composition containing losartan and hydrochlorothiazidum |
| 02/27/2013 | CN101461810B Oral solid medicament composition containing lafutidine |
| 02/27/2013 | CN101389628B Indolopyridines as EG5 kinesin modulators |
| 02/27/2013 | CN101289408B Non-steroid progestogen receptor regulator, preparation thereof, pharmaceutical compositions and uses |
| 02/27/2013 | CN101277684B Microparticles with modified release of at least one active principle and oral galenic form comprising same |
| 02/27/2013 | CN101268058B 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 02/27/2013 | CN101265249B 4-position carbonyl nitrogen-containing derivative of 6-methoxy-4',7-dihydroxyisoflavone and medical use thereof |
| 02/27/2013 | CN101254242B Applications of Chinese medicinal composition for preparing inhibition angiotensin II receptor |
| 02/27/2013 | CN101223179B Biologically active compounds obtainable from sorangium cellulosum |
| 02/27/2013 | CN101213301B Rnai for control of insects and arachnids |
| 02/27/2013 | CN101022796B Method for inhibiting tumor metastasis |
| 02/27/2013 | CN101010102B Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils |
| 02/26/2013 | US8383855 Histone deacetylase inhibitors |
| 02/26/2013 | US8383852 Compounds having a cyclic moiety and compositions for delivering active agents |
| 02/26/2013 | US8383827 Aryl pyridine as aldosterone synthase inhibitors |
| 02/26/2013 | US8383826 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/26/2013 | US8383825 Kinase inhibitors |
| 02/26/2013 | US8383824 Heterocyclic antiviral compounds |
| 02/26/2013 | US8383823 Substituted N-aryl pyridinones |
| 02/26/2013 | US8383822 Substituted oxazolidinones and their use |
| 02/26/2013 | US8383821 NK-1 and serotonin transporter inhibitors |
| 02/26/2013 | US8383820 N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase |
| 02/26/2013 | US8383817 Benztropine compounds and uses thereof |
| 02/26/2013 | US8383812 N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 02/26/2013 | US8383811 Process for preparing efavirenz polymorph |
| 02/26/2013 | US8383799 Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
| 02/26/2013 | US8383790 Modified surface antigen |
| 02/26/2013 | US8383787 Use of lipid conjugates in the treatment of diseases |
| 02/26/2013 | US8383786 Pesticidal compositions |
| 02/26/2013 | US8383785 Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides |
| 02/26/2013 | US8383687 Microemulsion preparation of high concentration propofol for anesthetic uses |
| 02/26/2013 | US8383686 Foaming alcohol compositions with selected dimethicone surfactants |
| 02/26/2013 | US8383685 Use of RR/SR-ractopamine |
| 02/26/2013 | US8383683 Pharmaceutical use of substituted amides |
| 02/26/2013 | US8383682 Mixed ligand surface-modified nanoparticles |
| 02/26/2013 | US8383681 Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders or attention deficit disorders |
| 02/26/2013 | US8383680 Composition comprising free amino acids |
| 02/26/2013 | US8383679 Crystal form of calcium 3-acetylaminopropane-1-sulfonate |
| 02/26/2013 | US8383678 Type a gelatin capsule containing PUFA in free acid form |
| 02/26/2013 | US8383677 Nerve-regenerating agent |
| 02/26/2013 | US8383675 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications |
| 02/26/2013 | US8383674 Synthesis of silver nanoclusters on zeolite substrates |
| 02/26/2013 | US8383673 Nitridoosmium(VI) complexes for treatment of cancer |
| 02/26/2013 | US8383672 Halogenated rhodamine derivatives and applications thereof |
| 02/26/2013 | US8383671 Method of treating malignant solid tumors |
| 02/26/2013 | US8383670 Trisubstituted thiophenes that modulate intracellular calcium |
| 02/26/2013 | US8383669 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 02/26/2013 | US8383668 11-beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 02/26/2013 | US8383666 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/26/2013 | US8383665 Immunomodulatory compositions |
| 02/26/2013 | US8383663 Bendamustine anionic-catioinic cyclopolysaccharide compositions |
| 02/26/2013 | US8383662 Bicyclic heteroaryl compounds |
| 02/26/2013 | US8383661 1,3 imidazolidine derivatives and their use in the production of carbapenem |
| 02/26/2013 | US8383660 Dibenzyl amine compounds and derivatives |
| 02/26/2013 | US8383659 Isoxazoline derivatives as pesticides |
| 02/26/2013 | US8383658 Isoxazole based neuronal nicotinic receptor ligands and methods of use |
| 02/26/2013 | US8383657 Thiazolylidine urea and amide derivatives and methods of use thereof |
| 02/26/2013 | US8383656 Thiazolidinedione energy restriction-mimetic agents |
| 02/26/2013 | US8383655 Modulators of pharmacokinetic properties of therapeutics |
| 02/26/2013 | US8383654 Heterocyclic antagonists of prostaglandin D2 receptors |
| 02/26/2013 | US8383653 SIR2 regulation |
| 02/26/2013 | US8383652 Biaromatic compounds that modulate PPAR-receptors |
| 02/26/2013 | US8383651 Compounds which selectively modulate the CB2 receptor |
| 02/26/2013 | US8383650 Organic compounds |
| 02/26/2013 | US8383649 Crystalline forms of naltrexone methobromide |
| 02/26/2013 | US8383648 Applying such as 1-oxyl-4-(3'-ethoxy-2',2'-dimethyl)propanecarbonyloxy-2,2,6,6-tetramethylpiperidine to eye surface; halting growth, preventing surgery |
| 02/26/2013 | US8383647 Quinoline derivative |
| 02/26/2013 | US8383646 Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds |
| 02/26/2013 | US8383645 Stable laquinimod preparations |
| 02/26/2013 | US8383644 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
| 02/26/2013 | US8383643 Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| 02/26/2013 | US8383642 Spiropiperidine compounds |
| 02/26/2013 | US8383641 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 02/26/2013 | US8383640 Substituted pyrimidine ether compounds and use thereof |
| 02/26/2013 | US8383639 HIV integrase inhibitors |
| 02/26/2013 | US8383638 Aminobenzoquinazolinone M1 receptor positive allosteric modulators |
| 02/26/2013 | US8383637 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| 02/26/2013 | US8383636 Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase |
| 02/26/2013 | US8383635 Chemical compounds |
| 02/26/2013 | US8383634 Methods of treatment using heteroaryl compounds and compositions thereof |
| 02/26/2013 | US8383633 Aminopyrimidines useful as kinase inhibitors |
| 02/26/2013 | US8383632 Method for making cetirizine tablets |
| 02/26/2013 | US8383631 1,6-disubstituted-3-amino-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-C]pyridin-7-one compounds and preparation thereof |
| 02/26/2013 | US8383630 Azaindazole compounds and methods of use |
| 02/26/2013 | US8383629 Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
| 02/26/2013 | US8383628 Pyridyl derivatives and their use as therapeutic agents |
| 02/26/2013 | US8383627 Crystalline polymorph of doxazosin mesylate (form IV) and process for preparation thereof |
| 02/26/2013 | US8383626 Nitric oxide donors for inducing neurogenesis |
| 02/26/2013 | US8383625 Pyrrolidinium derivatives as M3 muscarnic receptor antagonists |
| 02/26/2013 | US8383624 Pyrrolopyrazine inhibitors of kinases |
| 02/26/2013 | US8383623 Phthalazin-(2H)-one inhibitors of kinases |
| 02/26/2013 | US8383622 Nitrogen-containing heterocyclic derivative having 11β-hydroxysteroid dehydrogenase type I inhibitory activity |
| 02/26/2013 | US8383621 Acylpiperazinones and their use as pharmaceuticals |
| 02/26/2013 | US8383620 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 02/26/2013 | US8383619 Pharmaceutical compounds |
| 02/26/2013 | US8383618 C2-fluoro substituted piperazine linked pyrrolo[2,1-C][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 02/26/2013 | US8383617 Treatment of protein aggregation diseases |
| 02/26/2013 | US8383616 Aryl isoxazole compounds with antitumoural activities |
| 02/26/2013 | US8383615 Azetidine 2-carboxamide derivatives which modulate the CB2 receptor |